The American Association for Geriatric Psychiatry (AAGP) is the only national association that has products, activities and publications, which focus exclusively on the challenges of geriatric psychiatry. Practitioners, researchers, educators, students, the public—anyone interested in improving the mental health of the elderly—have relied on AAGP since 1978 as the key driver for progress for elderly mental health care.
The American Journal of Geriatric Psychiatry is the authoritative source of information for the rapidly developing field of geriatric psychiatry. The Journal is a benefit of AAGP membership; non-members can subscribe. The Journal contains peer-reviewed articles on the diagnosis and classification of psychiatric disorders of later life, epidemiological and biological correlates of mental health of older adults, and psychopharmacology and other somatic treatments. The Journal is published twelve times a year.
Indexed by Index Medicus Current Contents (Life Sciences, Clinical Medicine), Social & Behavioral Sciences, Social Sciences Citation Index, Science Citation Index, SciSearch Database, ISI/BioMed, Research Alert), EMBASE/Excerpta medica, BIOSIS, Chemical Abstracts, Sociological Abstracts, Biological Abstracts, PsycINFO, and CINAHL.
The use of new technologies in geriatric psychiatry shows promise for advancing personalized medicine and improving patient care. A new study in The American Journal of Geriatric Psychiatry describes the successful adaptation of an integrated medical and psychiatric self-management intervention to a smartphone application for middle-aged and older adults with serious mental illness.
The editors of The American Journal of Geriatric Psychiatry are grateful for the extraordinary response from the international community to our call for papers on COVID-19. Thus far, the journal has received over 120 submissions and accepted papers are openly available online as part of the journal’s COVID-19 collection.
As the acute crisis of the pandemic and resulting lockdowns subside, the journal is ending its formal call for papers on this topic. We will continue to treat COVID-19 as an area of high interest and will prioritize submissions that present original data to guide care, research and policy. We anticipate that accepted manuscripts on this topic will continue to be openly available until further notice. All submitted manuscripts will be subject to peer review. The American Journal of Geriatric Psychiatry anticipates remaining in its current role as an authoritative source of knowledge on COVID-19 and its impact on the mental health of older adults.
The American Journal of Geriatric Psychiatry app now available for iOS and Android